Skip to main content

What studies or clinical trials back Amissa’s data analysis?

Updated over a month ago

What studies or clinical trials support Amissa’s data analysis?

Amissa’s platform is informed by expert research partnerships and supported by federal funding, but it is not itself a published clinical trial.

We work with leading clinical institutions and research teams to ensure that the science and methodology behind our data analysis are grounded in validated research principles.


Evidence and research partnerships

Institutional collaborations
Amissa collaborates with expert clinicians and researchers from respected institutions such as:

  • Mass General

  • Washington University School of Medicine

  • Wake Forest University

  • Other academic and clinical partners

These collaborations help guide our approach to data modeling and analytics.


Federal research support
Amissa has received funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF). This support has helped advance projects related to:

  • Machine learning and predictive analytics

  • Wearable data collection methods

  • Disease-specific research initiatives, including Alzheimer’s disease studies


Where to go

If you are interested in learning how Amissa’s data and analytics might support your research, or if you are exploring IRB-backed collaborations or funding opportunities, please contact our research team through amissa.com!

Did this answer your question?